End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.33 CNY | +2.06% |
|
+5.04% | -7.09% |
Jan. 29 | BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma | MT |
Oct. 25 | Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
Evolution of the Average Target: Changchun BCHT Biotechnology Co.
Evolution of the Target Price: Changchun BCHT Biotechnology Co.
Changes in Analyst Recommendations: Changchun BCHT Biotechnology Co.
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+37.1% | ||||||
+30.31% | ||||||
+42.26% | ||||||
+13.4% | ||||||
+1.59% | ||||||
+1.2% | ||||||
+2.15% | ||||||
- | - | +65.99% | ||||
+11.98% | ||||||
Average | +22.89% | |||||
Weighted average by Cap. | +25.49% |
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 688276 Stock
- Consensus Changchun BCHT Biotechnology Co.